<?xml version="1.0" encoding="UTF-8"?>
<p>Despite initial success, shortly after the launch of selective COX-2 inhibitors, adverse cardiovascular and renal effects have been reported and, in high-doses, gastrointestinal effects. These adverse effects occur due to inhibition of the constitutive production of COX-2 in some tissues. Thus, in recent years, the safety of the use of NSAIDs in clinical practice has been questioned, due to the emergence of evidence that suggests a high risk of acute myocardial infarction, stroke, heart failure, renal failure, and arterial hypertension [
 <xref rid="B30-molecules-25-03726" ref-type="bibr">30</xref>,
 <xref rid="B38-molecules-25-03726" ref-type="bibr">38</xref>].
</p>
